1. Armstrong B, Doll R. Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits. British Journal of Preventive & Social Medicine. 1975;29:73–81. [PMC free article: PMC478894] [PubMed: 1182356]
  2. Arnold D, Moodie C, Grice H, Charbonneau S, Stavric B, Collins B, McGuire P, Zawidzka Z, Monro I. Long term toxicity of ortho-toluenesulfonamide and sodium saccharin in the rat. Toxicology and Applied Pharmacology. 1980;52:113–152. [PubMed: 7361306]
  3. Ashby J. The genotoxicity of sodium saccharin and sodium chloride in relation to their cancer-promoting properties. Food and Chemical Toxicology. 1985;23:507–519. [PubMed: 3891557]
  4. Baines C. Transparency at the International Agency for Research on Cancer. Lancet. 2003;361(9359):781–782. [PubMed: 12620754]
  5. EIA (Energy Information Administration). International Energy Annual. 2004. [accessed May 5, 2008]. http://eia​.doe.gov/iea.
  6. EIA. Projections: EIA, System for the Analysis of Global Energy Markets. 2007. [accessed May 5, 2008]. http://eia​.doe.gov/iea.
  7. EU (European Union). Europa Glossary. 2008. [accessed April 10, 2008]. http://europa​.eu/scadplus​/glossary/precautionary​_principle_en.htm.
  8. FDA (Food and Drug Administration). New Federal Health Initiative to Improve Cancer Therapy. 2006. [accessed March 20, 2008]. http://www​.fda.gov/bbs​/topics/news/2006/NEW01316.html.
  9. Gohlke J, Portier C. The forest for the trees: A systems approach to human health research. Environmental Health Perspectives. 2007;115(9):1261–1263. [PMC free article: PMC1964909] [PubMed: 17805413]
  10. Hastein T, Hjeltnes B, Lillehaug A, Utne Skare J, Berntssen M, Lundebye AK. Food safety hazards that occur during the production stage: Challenges for fish farming and the fishing industry. Revues Scientifique et Technique. 2006;25(2):18. [PubMed: 17094701]
  11. Hattis D. Draft risk analysis ideals. Human and Ecological Risk Assessment. 2000;6(6):7.
  12. Hattis D. The conception of variability in risk analyses: Developments since 1980. In: McDaniels T, Small MJ, editors. Risk Analysis and Society: An Interdisciplinary Characterization of the Field. Cambridge, England: Cambridge University Press; 2004. pp. 15–45.
  13. Hattis DA, Anderson EL. What should be the implications of uncertainty, variability, and inherent “biases”/”conservatism” for risk management decision-making? Society for Risk Analysis. 1999;19(1):13.
  14. HHS (U.S. Department of Health and Human Services) and NTP (National Toxicology Program). Report on Carcinogens. 1th ed. Washington, DC: HHS and NTP; 2005.
  15. IARC. IARC monographs on the evaluation of the carcinogenic risks to humans. Genetic and Related Effects: An Updating of Selected IARC Monographs from Volumes 1–42. 1987;(Suppl 6):488–496. [PubMed: 3504843]
  16. IARC. Preamble to the IARC Monographs. 2006. [accessed November 12, 2008]. http://monographs​.iarc​.fr/ENG/Preamble/currenta2objective0706.php.
  17. Majone G. The precautionary principle and its policy implications. Journal of Common Market Studies. 2002;40:89–110.
  18. NTP (National Toxicology Program). Questions and Answers About the Report on Carcinogens. 2005. [accessed May 5, 2008]. http://ntp​.niehs.nih​.gov/index.cfm?objectid​=03CA6383-97566-1F64-6637241FE0114FE9.
  19. NTP. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Mission and Vision. 2008. [accessed May 5, 2008]. http://iccvam​.niehs.nih​.gov/about/ni_Mission.htm.
  20. OMB (Office of Management and Budget). Proposed Risk Assessment Bulletin. 2006. [accessed May 9, 2008]. http://www​.whitehouse​.gov/omb/inforeg/proposed​_risk_assessment_bulletin_010906​.pdf.
  21. Palucka T. Doing the impossible. Invention & Technology Magazine. 2004;19(3):22–31.
  22. Pearson SD, Sabin J, Emanuel EJ. No Margin, No Mission: Health-care Organizations and the Quest for Ethical Evidence. New York: Oxford University Press; 2003.
  23. Steinzor R, Shudtz M. Sequestering science: Secrets threatening public health. CPR White Paper. 2007 April;703
  24. SUNY (State University of New York). Guide to research methods: The evidence pyramid. 2004. [accessed November 11, 2008]. http://library​.downstate​.edu/EBM2/2100.htm.
  25. Sweatman T, Renwick A. Saccharin metabolism and tumorigenicity. Science. 1979;205:1019–1020. [PubMed: 472722]
  26. Taylor J, Weinberger M, Friedman L. Chronic toxicity and carcinogenicity to the urinary bladder of sodium saccharin in the in utero–exposed rat. Toxicology and Applied Pharmacology. 1980;54:57–75. [PubMed: 7394788]
  27. Teutsch SM. The evidence for evidence-based public health. Journal of Public Health Management and Practice. 2008;14(2):92–93. [PubMed: 18287912]
  28. Tisdel M, Nees P, Harris D, Derse P. Symposium: Sweeteners. Westport, CT: Avi Publishing Co.; 1974. Long-term feeding of saccharin in rats; pp. 145–158.
  29. United Nations. The Rio Declaration on Environment and Development. United Nations Conference on Environment and Development; June 13–14; Rio de Janeiro. 1992.
  30. Wagner W, Steinzor R. Rescuing science from politics: Regulating and the distortion of scientific research. CPR White Paper. 2006 August:604.
  31. Whysner J, Williams G. Saccharin mechanistic data and risk assessment: Urine composition, enhanced cell proliferation, and tumor promotion. Pharmacology and Therapeutics. 1996;71:225–252. [PubMed: 8910956]